NasdaqGS - Delayed Quote • USD
Galapagos NV (GLPG)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:59 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-405,970.00
-405,970.00
-500,544.00
-503,827.00
-427,336.00
Investing Cash Flow
71,186.00
71,186.00
-1,245,514.00
541,238.00
757,288.00
Financing Cash Flow
-5,001.00
-5,001.00
-1,487.00
-3,876.00
22,040.00
End Cash Position
--
--
508,117.00
2,233,368.00
2,143,071.00
Capital Expenditure
-19,273.00
-19,273.00
-36,947.00
-57,879.00
-91,315.00
Repayment of Debt
-6,771.00
-6,771.00
-8,182.00
-7,190.00
-6,247.00
Free Cash Flow
-425,243.00
-425,243.00
-537,491.00
-561,706.00
-518,651.00
12/31/2020 - 2/27/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASMB Assembly Biosciences, Inc.
13.48
+1.58%
CTMX CytomX Therapeutics, Inc.
1.6300
-2.98%
EIGRQ Eiger BioPharmaceuticals, Inc.
3.7975
-3.86%
NXTC NextCure, Inc.
1.4400
-5.88%
SPRO Spero Therapeutics, Inc.
1.4200
-1.05%
TIL Instil Bio, Inc.
10.71
+1.04%
PRTC PureTech Health plc
27.48
-2.55%
CLRB Cellectar Biosciences, Inc.
3.0600
-1.61%
GLTO Galecto, Inc.
0.6710
-4.22%
ACHL Achilles Therapeutics plc
0.7838
+0.10%